Three early-career researchers thrown together on Sable Island, a treeless island in the North Atlantic, think others can learn from their experiences.

A phase 2 study showed a 93.3% objective response rate for lenvatinib and tislelizumab in FH-RCC patients, with a 20% complete response rate. FH-RCC is driven by FH gene mutations, leading to ...

Alphabet (GOOG, GOOGL) expects to spend $75 billion in capital expenditures in 2025, adding to the billions of dollars Big Tech companies are investing in artificial intelligence (AI). "The growth ...

Renal cell carcinoma (RCC) refers to a heterogenous group of cancers that originate in the proximal convoluted tubule of the kidney. The three most common forms of RCC are clear cell RCC ...

Join our daily and weekly newsletters for the latest updates and exclusive content on industry-leading AI coverage. Learn More (Updated Monday, 1/27 8am) DeepSeek-R1’s release last Monday has ...